{
    "clinical_study": {
        "@rank": "117767", 
        "arm_group": {
            "arm_group_label": "Psoriatic Arthritis patients treated with Anti-TNF", 
            "description": "Psoriatic Arthritis patients treated with Anti-TNF"
        }, 
        "brief_summary": {
            "textblock": "This post marketing observational study (PMOS) is designed to provide the initial data on\n      work impairment of Psoriatic Arthritis (PsA) patients in Turkey, as well as changes in work\n      impairment, life quality and clinical response during treatment with anti-TNF agents."
        }, 
        "brief_title": "To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis", 
        "completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Psoriatic Arthritis", 
            "Work Productivity"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Psoriatic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Actively working, either full-time or part-time\n\n          2. Previous confirmed diagnosis of PsA by a rheumatologist\n\n          3. Patients for whom the physician has initiated PsA treatment with an Anti-TNF in\n             accordance with Turkish Ministry of Health regulations and reimbursement criteria\n\n          4. Able to provide authorization to use and disclose their health related information\n\n        Exclusion Criteria:\n\n          1. Patients with a history of an allergic reaction or significant sensitivity to\n             anti-TNF agents\n\n          2. Patients with possible follow-up problems during the planned study period or patients\n             who may not be compliant to treatment as evaluated by the investigator/treating\n             physician\n\n          3. Patients participating in any clinical trial of an experimental drug 30 days prior to\n             the first visit"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients from both genders will be included to this non-interventional epidemiological\n        study from selected university or state hospital or  Ministry of Health of Turkey training\n        and research hospitals in Turkey."
            }
        }, 
        "enrollment": {
            "#text": "125", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 3, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02028169", 
            "org_study_id": "P13-518"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Psoriatic Arthritis", 
            "Anti-TNFs", 
            "Work Productivity"
        ], 
        "lastchanged_date": "May 1, 2014", 
        "link": {
            "url": "http://www.rxabbvie.com"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Adana", 
                        "country": "Turkey"
                    }, 
                    "name": "Site Reference ID/Investigator# 119217"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 119217", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ankara", 
                        "country": "Turkey", 
                        "zip": "06500"
                    }, 
                    "name": "Site Reference ID/Investigator# 126115"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 126115", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ankara", 
                        "country": "Turkey", 
                        "zip": "06100"
                    }, 
                    "name": "Site Reference ID/Investigator# 98055"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 98055", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ankara", 
                        "country": "Turkey"
                    }, 
                    "name": "Site Reference ID/Investigator# 98079"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 98079", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Antalya", 
                        "country": "Turkey", 
                        "zip": "07058"
                    }, 
                    "name": "Site Reference ID/Investigator# 119219"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 119219", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bursa", 
                        "country": "Turkey", 
                        "zip": "16059"
                    }, 
                    "name": "Site Reference ID/Investigator# 98075"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 98075", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edirne", 
                        "country": "Turkey", 
                        "zip": "22030"
                    }, 
                    "name": "Site Reference ID/Investigator# 126114"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 126114", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Elazig", 
                        "country": "Turkey", 
                        "zip": "23119"
                    }, 
                    "name": "Site Reference ID/Investigator# 98056"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 98056", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Eskisehir", 
                        "country": "Turkey", 
                        "zip": "26480"
                    }, 
                    "name": "Site Reference ID/Investigator# 98059"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 98059", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gaziantep", 
                        "country": "Turkey"
                    }, 
                    "name": "Site Reference ID/Investigator# 98078"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 98078", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Istanbul", 
                        "country": "Turkey"
                    }, 
                    "name": "Site Reference ID/Investigator# 67502"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Istanbul", 
                        "country": "Turkey"
                    }, 
                    "name": "Site Reference ID/Investigator# 98077"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Istanbul", 
                        "country": "Turkey"
                    }, 
                    "name": "Site Reference ID/Investigator# 98080"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 98080", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Izmir", 
                        "country": "Turkey"
                    }, 
                    "name": "Site Reference ID/Investigator# 98060"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 98060", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Konya", 
                        "country": "Turkey", 
                        "zip": "42075"
                    }, 
                    "name": "Site Reference ID/Investigator# 98057"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 98057", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mersin", 
                        "country": "Turkey", 
                        "zip": "33050"
                    }, 
                    "name": "Site Reference ID/Investigator# 98076"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 98076", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sakarya", 
                        "country": "Turkey", 
                        "zip": "41380"
                    }, 
                    "name": "Site Reference ID/Investigator# 98058"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Samsun", 
                        "country": "Turkey", 
                        "zip": "55139"
                    }, 
                    "name": "Site Reference ID/Investigator# 126113"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 126113", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_groups": "1", 
        "official_title": "To Observe the Impacts of Anti-TNF's Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis", 
        "overall_contact": {
            "email": "imge.guneshan@abbvie.com", 
            "last_name": "Imge  Guneshan, BS Pharm", 
            "phone": "+90 216 636 0600"
        }, 
        "overall_contact_backup": {
            "email": "senem.kurtis@abbvie.com", 
            "last_name": "Senem G\u00fclc\u00fc Kurtis, BS Pharm", 
            "phone": "+90 216 636 0600"
        }, 
        "overall_official": {
            "affiliation": "AbbVie", 
            "last_name": "Mahmut  Gucuk, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Turkey: Ethics Committee", 
                "Turkey: Ministry of Health"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "To collect the number of missed working days and the number of working days", 
                "measure": "Evaluation of the impact of long term treatment of psoriatic arthritis with anti-TNFs on Absenteeism", 
                "safety_issue": "No", 
                "time_frame": "Up to Month 9"
            }, 
            {
                "description": "To collect the number of working days and the total number of working days", 
                "measure": "Evaluation of the impact of long term treatment of psoriatic arthritis with anti-TNFs on Presenteeism", 
                "safety_issue": "No", 
                "time_frame": "Up to Month 9"
            }, 
            {
                "description": "To collect overall work impairment", 
                "measure": "Evaluation of the impact of long term treatment of psoriatic arthritis with anti-TNFs on work productivity", 
                "safety_issue": "No", 
                "time_frame": "Up to Month 9"
            }, 
            {
                "description": "To collect total daily activity impairment by Work Productivity and Activity Impairment (WPAI) questionnaire", 
                "measure": "Evaluation of the impact of long term treatment of psoriatic arthritis with anti-TNFs on total daily activity impairment", 
                "safety_issue": "No", 
                "time_frame": "Up to Month 9"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02028169"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "To evaluate Self-reported functional status (disability)", 
                "measure": "To collect Self-reported functional status using Health Assessed Questionnaire (HAQ) questionnaire", 
                "safety_issue": "No", 
                "time_frame": "Up to Month 9"
            }, 
            {
                "description": "To evaluate the effectiveness of Anti-TNF treatment", 
                "measure": "Evaluation of the Anti-TNF treatment effectiveness based percentage of patients achieving American College Rheumatology (ACR) 20/ACR50", 
                "safety_issue": "No", 
                "time_frame": "Up to Month 9"
            }, 
            {
                "description": "To evaluate the effectiveness of Anti-TNF treatment", 
                "measure": "Evaluation of the Anti-TNF treatment effectiveness based percentage of patients achieving ACR 70", 
                "safety_issue": "No", 
                "time_frame": "Up to Month 9"
            }, 
            {
                "description": "To evaluate the effectiveness of Anti-TNF treatment", 
                "measure": "Change in Disease Activity Score (DAS 28)", 
                "safety_issue": "No", 
                "time_frame": "Up to 9 months"
            }, 
            {
                "description": "To evaluate the effectiveness of Anti-TNF treatment", 
                "measure": "Change in Maastricht Ankylosing Spondylitis Enthesitis Score", 
                "safety_issue": "No", 
                "time_frame": "Up to 9 months"
            }, 
            {
                "description": "To evaluate the effectiveness of Anti-TNF treatment", 
                "measure": "Change in dactylytis", 
                "safety_issue": "No", 
                "time_frame": "Up to Month 9"
            }, 
            {
                "description": "To evaluate the effectiveness of Anti-TNF treatment", 
                "measure": "Number of swollen and/or tender joints", 
                "safety_issue": "No", 
                "time_frame": "Up to Month 9"
            }, 
            {
                "description": "To evaluate the effectiveness of Anti-TNF treatment", 
                "measure": "Change in levels of rheumatoid factor", 
                "safety_issue": "No", 
                "time_frame": "Up to Month 9"
            }, 
            {
                "description": "To evaluate the effectiveness of Anti-TNF treatment", 
                "measure": "Change in Erythrocyte Sedimentation Rate (ESR)", 
                "safety_issue": "No", 
                "time_frame": "Up to Month 9"
            }, 
            {
                "description": "To evaluate the effectiveness of Anti-TNF treatment", 
                "measure": "Change in C-reactive protein (CRP)", 
                "safety_issue": "No", 
                "time_frame": "Up to Month 9"
            }, 
            {
                "description": "To collect physician's and patient's global assessment of disease activity and disease related pain and fatigue to evaluate the effectiveness of Anti-TNF treatment", 
                "measure": "Change in Visual Analog Scale (VAS)", 
                "safety_issue": "No", 
                "time_frame": "Up to Month 9"
            }, 
            {
                "description": "To report serious adverse events (SAE) occurring during treatment with anti-TNF agents", 
                "measure": "Number of patients with serious adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "Up to Month 9"
            }
        ], 
        "source": "AbbVie", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AbbVie", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}